A detailed history of Trinity Point Wealth, LLC transactions in Incyte Corp stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 20,638 shares of INCY stock, worth $1.47 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
20,638
Previous 19,959 3.4%
Holding current value
$1.47 Million
Previous $1.21 Million 12.82%
% of portfolio
0.2%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$57.33 - $68.61 $38,927 - $46,586
679 Added 3.4%
20,638 $1.36 Million
Q2 2024

Jul 30, 2024

BUY
$51.18 - $63.75 $93,557 - $116,535
1,828 Added 10.08%
19,959 $1.21 Million
Q1 2024

May 08, 2024

BUY
$56.55 - $66.59 $1.03 Million - $1.21 Million
18,131 New
18,131 $1.03 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Trinity Point Wealth, LLC Portfolio

Follow Trinity Point Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.